The advancements in the management and the treatment of cancer proved to be rewarding according to a report released by the American Cancer Society. The report mentioned that cancer rates in the U.S. have gone down at the quickest pace ever. This can be credited to the reduction in smoking rates hence downsizing the lung-cancer mortality rates. It goes without saying, the improvements in surgery and diagnostic methods as significantly contributed to this. However, as one cause for American mortality declined, other causes seemed to have risen. There are many causes of death, like deaths from liver disease and alcohol-related illnesses have been on the rise with nearly 73,000 Americans dying from them as of 2017, this number is twice as that of the number in 1999. With a majority of the drug companies going after cancer-related medicines, developers of antibiotics and medicines that treat other diseases are going bankrupt. This is why growth and improvement in the treatment of diseases like Alzheimer’s, hepatitis C and HPV remain stagnant. It is upon the government to provide funds and incentives to encourage researchers to take up big challenges and focus on ranges of unmet needs. That being said, it is also important to acknowledge public efforts in the prevention of any disease. Given the high cost of medications and their limited efficacy, prevention is the option to go for. There is room for growth and change leading to significant advancement, proper planning, economic policies, and their implementation is required if we are to see some real change in the future of healthcare.